Parkinson’s Disease Treatment Drug Reports Deaths Spark

April 10, 2018 Categories: Dangerous Drugs

Pin It

Parkinson’s Disease Treatment Drug Reports Deaths Spark

NuplazidA new medication called Nuplazid, made by San Diego-based Acadia Pharmaceuticals had been designated a “breakthrough therapy” – meaning that it demonstrated “substantial improvement” in patients with serious or life-threatening diseases compared to treatments already on the market.

The physician who led the FDA’s medical review, Dr. Paul Andreason, warned that patients taking the drug during the company’s clinical trials experienced serious outcomes, including death, at more than double the rate of those taking the placebo. The company’s limited testing, he said, had not convinced him that the benefits outweighed the risks.


Your Comment

Recent Updates

It has been a few years since Roundup®, a product of Monsanto, was reportedly linked to a serious disease called non-Hodgkin lymphoma. People who worked with the weed-killer Roundup® across the United States were exposed to glyphosate, which is the main ingredient in the most popular herbicide in the country. Case of DeWayne Johnson against...

July 25, 2018

The FDA issued a safety alert in December 2017, stating that some patients who received a gadolinium-based contrast during an MRI procedure, may retain the gadolinium in their bodies for months, or even for years, causing serious side effects. Gadolinium is commonly used in MRIs to enhance the images the test provides. Gadolinium is a...

July 18, 2018

Johnson & Johnson must pay $4.14 billion in punitive damages after a jury found that plaintiffs’ ovarian cancers were caused by asbestos in Johnson & Johnson’s talcum powder products. Popular products like Shower-to-Shower, and “Johnson’s Baby Powder” have been linked to ovarian cancer after regular use. 22 plaintiffs were awarded $25 million each. Johnson &...

July 16, 2018